269 related articles for article (PubMed ID: 9646769)
21. Bone morphogenetic protein gene therapy using a fibrin scaffold for a rabbit spinal-fusion experiment.
Lee TC; Ho JT; Hung KS; Chen WF; Chung YH; Yang YL
Neurosurgery; 2006 Feb; 58(2):373-80; discussion 373-80. PubMed ID: 16462492
[TBL] [Abstract][Full Text] [Related]
22. rhBMP-6 stimulated osteoprogenitor cells enhance posterolateral spinal fusion in the New Zealand white rabbit.
Valdes M; Moore DC; Palumbo M; Lucas PR; Robertson A; Appel J; Ehrlich MG; Keeping HS
Spine J; 2007; 7(3):318-25. PubMed ID: 17482115
[TBL] [Abstract][Full Text] [Related]
23. The effects of bone morphogenetic protein and basic fibroblast growth factor on cultured mesenchymal stem cells for spine fusion.
Minamide A; Yoshida M; Kawakami M; Okada M; Enyo Y; Hashizume H; Boden SD
Spine (Phila Pa 1976); 2007 May; 32(10):1067-71. PubMed ID: 17471086
[TBL] [Abstract][Full Text] [Related]
24. Comparison of lentiviral and adenoviral gene therapy for spinal fusion in rats.
Miyazaki M; Sugiyama O; Zou J; Yoon SH; Wei F; Morishita Y; Sintuu C; Virk MS; Lieberman JR; Wang JC
Spine (Phila Pa 1976); 2008 Jun; 33(13):1410-7. PubMed ID: 18475244
[TBL] [Abstract][Full Text] [Related]
25. The adjunctive effect of a binding peptide on bone morphogenetic protein enhanced bone healing in a rodent model of spinal fusion.
Alanay A; Chen C; Lee S; Murray SS; Brochmann EJ; Miyazaki M; Napoli A; Wang JC
Spine (Phila Pa 1976); 2008 Jul; 33(16):1709-13. PubMed ID: 18580546
[TBL] [Abstract][Full Text] [Related]
26. Enhancing effects of a prostaglandin EP4 receptor agonist on recombinant human bone morphogenetic protein-2 mediated spine fusion in a rabbit model.
Namikawa T; Terai H; Hoshino M; Kato M; Toyoda H; Yano K; Nakamura H; Takaoka K
Spine (Phila Pa 1976); 2007 Oct; 32(21):2294-9. PubMed ID: 17906568
[TBL] [Abstract][Full Text] [Related]
27. The effect of platelet-rich plasma and bone marrow on murine posterolateral lumbar spine arthrodesis with bone morphogenetic protein.
Rao RD; Gourab K; Bagaria VB; Shidham VB; Metkar U; Cooley BC
J Bone Joint Surg Am; 2009 May; 91(5):1199-206. PubMed ID: 19411469
[TBL] [Abstract][Full Text] [Related]
28. Experimental spinal fusion using sintered bovine bone coated with type I collagen and recombinant human bone morphogenetic protein-2.
Minamide A; Tamaki T; Kawakami M; Hashizume H; Yoshida M; Sakata R
Spine (Phila Pa 1976); 1999 Sep; 24(18):1863-70; discussion 1871-2. PubMed ID: 10515009
[TBL] [Abstract][Full Text] [Related]
29. [Experiment of rhBMP-2 in posterolateral spinal fusion in aged rabbits].
Duan XW; Wu H; Gu CY; Yu Y; Yang XY; Wei J; Duan DS
Zhongguo Gu Shang; 2010 Jan; 23(1):28-32. PubMed ID: 20191960
[TBL] [Abstract][Full Text] [Related]
30. Accelerating lumbar fusions by combining rhBMP-2 with allograft bone: a prospective analysis of interbody fusion rates and clinical outcomes.
Slosar PJ; Josey R; Reynolds J
Spine J; 2007; 7(3):301-7. PubMed ID: 17482113
[TBL] [Abstract][Full Text] [Related]
31. Autograft containment in posterolateral spine fusion.
Rao RD; Bagaria V; Gourab K; Haworth ST; Shidham VB; Cooley BC
Spine J; 2008; 8(4):563-9. PubMed ID: 17923443
[TBL] [Abstract][Full Text] [Related]
32. Delivery of recombinant human bone morphogenetic protein-2 using a compression-resistant matrix in posterolateral spine fusion in the rabbit and in the non-human primate.
Suh DY; Boden SD; Louis-Ugbo J; Mayr M; Murakami H; Kim HS; Minamide A; Hutton WC
Spine (Phila Pa 1976); 2002 Feb; 27(4):353-60. PubMed ID: 11840099
[TBL] [Abstract][Full Text] [Related]
33. In vivo evaluation of plasmid DNA encoding OP-1 protein for spine fusion.
Bright C; Park YS; Sieber AN; Kostuik JP; Leong KW
Spine (Phila Pa 1976); 2006 Sep; 31(19):2163-72. PubMed ID: 16946649
[TBL] [Abstract][Full Text] [Related]
34. The efficacy of rhBMP-2 for posterolateral lumbar fusion in smokers.
Glassman SD; Dimar JR; Burkus K; Hardacker JW; Pryor PW; Boden SD; Carreon LY
Spine (Phila Pa 1976); 2007 Jul; 32(15):1693-8. PubMed ID: 17621221
[TBL] [Abstract][Full Text] [Related]
35. Structural characteristics of repair tissue of cricoid cartilage defects treated with recombinant human bone morphogenetic protein-2.
Tcacencu I; Carlsöö B; Stierna P
Wound Repair Regen; 2004; 12(3):346-50. PubMed ID: 15225213
[TBL] [Abstract][Full Text] [Related]
36. Experimental spinal fusion with recombinant human bone morphogenetic protein-2.
Schimandle JH; Boden SD; Hutton WC
Spine (Phila Pa 1976); 1995 Jun; 20(12):1326-37. PubMed ID: 7676329
[TBL] [Abstract][Full Text] [Related]
37. Effect of teriparatide [rhPTH(1,34)] and calcitonin on intertransverse process fusion in a rabbit model.
Lehman RA; Dmitriev AE; Cardoso MJ; Helgeson MD; Christensen CL; Raymond JW; Eckel TT; Riew KD
Spine (Phila Pa 1976); 2010 Jan; 35(2):146-52. PubMed ID: 20081509
[TBL] [Abstract][Full Text] [Related]
38. Temporal and Spatial Expression of BMPs and BMP Antagonists During Posterolateral Lumbar Fusion.
Tang Y; Ye X; Klineberg EO; Curtiss S; Maitra S; Gupta MC
Spine (Phila Pa 1976); 2011 Feb; 36(4):E237-44. PubMed ID: 21099737
[TBL] [Abstract][Full Text] [Related]
39. Effects of recombinant human bone morphogenetic protein 2 on surgical infections in a rabbit posterolateral lumbar fusion model.
Miller CP; Simpson AK; Whang PG; Erickson BP; Waked WR; Lawrence JP; Grauer JN
Am J Orthop (Belle Mead NJ); 2009 Nov; 38(11):578-84. PubMed ID: 20049353
[TBL] [Abstract][Full Text] [Related]
40. Lumbar spinal fusion with a mineralized collagen matrix and rhBMP-2 in a rabbit model.
Liao SS; Guan K; Cui FZ; Shi SS; Sun TS
Spine (Phila Pa 1976); 2003 Sep; 28(17):1954-60. PubMed ID: 12973141
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
